CME Group Inc (NASDAQ: CME) has seen a decline in its stock price by -0.75 in relation to its previous close of 209.64. However, the company has experienced a -2.13% decline in its stock price over the last five trading sessions. Forbes reported 2024-05-01 that CME Group’s stock (NYSE: CME) has made negligible gains YTD, as compared to the 7% rise in the S&P500 over the same period. Further, at its current price of $210 per share, it is trading 6% below its fair value of $224 – Trefis’ estimate for CME Group’s valuation.
Is It Worth Investing in CME Group Inc (NASDAQ: CME) Right Now?
CME Group Inc (NASDAQ: CME) has a higher price-to-earnings ratio of 23.69x compared to its average ratio. CME has 36-month beta value of 0.49. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 4 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for CME is 358.75M, and currently, short sellers hold a 0.99% ratio of that float. The average trading volume of CME on May 02, 2024 was 1.69M shares.
CME’s Market Performance
The stock of CME Group Inc (CME) has seen a -2.13% decrease in the past week, with a -3.13% drop in the past month, and a 1.08% gain in the past quarter. The volatility ratio for the week is 1.67%, and the volatility levels for the past 30 days are at 1.81% for CME. The simple moving average for the past 20 days is -1.47% for CME’s stock, with a 1.00% simple moving average for the past 200 days.
Analysts’ Opinion of CME
Many brokerage firms have already submitted their reports for CME stocks, with Barclays repeating the rating for CME by listing it as a “Equal Weight.” The predicted price for CME in the upcoming period, according to Barclays is $222 based on the research report published on January 08, 2024 of the current year 2024.
Goldman, on the other hand, stated in their research note that they expect to see CME reach a price target of $195. The rating they have provided for CME stocks is “Sell” according to the report published on January 03rd, 2024.
BofA Securities gave a rating of “Neutral” to CME, setting the target price at $204 in the report published on September 06th of the previous year.
CME Trading at -3.03% from the 50-Day Moving Average
After a stumble in the market that brought CME to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.54% of loss for the given period.
Volatility was left at 1.81%, however, over the last 30 days, the volatility rate increased by 1.67%, as shares sank -1.87% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.38% lower at present.
During the last 5 trading sessions, CME fell by -2.13%, which changed the moving average for the period of 200-days by +12.32% in comparison to the 20-day moving average, which settled at $210.98. In addition, CME Group Inc saw -1.20% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CME starting from DUFFY TERRENCE A, who sale 40,000 shares at the price of $210.91 back on Apr 29 ’24. After this action, DUFFY TERRENCE A now owns 67,455 shares of CME Group Inc, valued at $8,436,496 using the latest closing price.
SHEPARD WILLIAM R, the Director of CME Group Inc, purchase 282 shares at $214.71 during a trade that took place back on Mar 26 ’24, which means that SHEPARD WILLIAM R is holding 253,343 shares at $60,561 based on the most recent closing price.
Stock Fundamentals for CME
Current profitability levels for the company are sitting at:
- 0.62 for the present operating margin
- 0.83 for the gross margin
The net margin for CME Group Inc stands at 0.57. The total capital return value is set at 0.03. Equity return is now at value 11.72, with 2.14 for asset returns.
Based on CME Group Inc (CME), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at 1.01. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is 21.84.
Currently, EBITDA for the company is 3.79 billion with net debt to EBITDA at 0.74. When we switch over and look at the enterprise to sales, we see a ratio of 13.67. The receivables turnover for the company is 8.95for trailing twelve months and the total asset turnover is 0.04.
Conclusion
To put it simply, CME Group Inc (CME) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
